Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Bolt Biotherapeutics

Request full access

Plans to develop a novel format for T-cell mediated anti-tumour therapy

Redwood City, United StatesFounded 2015Biotech & Life Sciences

About Bolt Biotherapeutics

Bolt Biotherapeutics operates in the biotechnology sector, focusing on the development of advanced immuno-oncology therapies. The company targets patients who do not respond to traditional checkpoint inhibitors, a significant portion of the cancer patient population. Bolt Biotherapeutics' proprietary platform reinvigorates the immune system by leveraging the capabilities of dendritic and other myeloid cells to generate effective anti-tumor immunity. This approach aims to create systemic immunological memory, offering durable clinical benefits. The company primarily serves the healthcare market, specifically targeting oncologists and cancer treatment centers. Bolt Biotherapeutics generates revenue through the development and commercialization of its unique class of immuno-oncology therapies, known as ISACs (Immune-Stimulating Antibody Conjugates). These therapies are designed to provide long-term benefits to cancer patients by enhancing their immune response to tumors.

Source: Dealroom company data

Bolt Biotherapeutics in the Redwood City ecosystem

Live from Dealroom

The Bolt Biotherapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

10 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Pivotal Life Sciences
  • Novo Holdings
  • Vivo Capital
  • Nan Fung Life Sciences Real Estate

Series B and later6 investors entered at this stage

  • Sofinnova Investments
  • RA Capital Management
  • Citadel
  • Samsara BioCapital
  • Rock Springs Capital
  • Pfizer Ventures
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

See Bolt Biotherapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.